Skip to content

Clinical trials

Observational Bipolar Disorder trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bipolar Disorder Phase: Observational Country / region: Germany Clear all

5 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20101
20151
20221
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca1
Eli Lilly and Company1
Forschungsinstitut der Diabetes Akademie Mergentheim1
Max-Planck-Institute of Psychiatry1
Technische Universität Dresden1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bipolar Disorder5
Anorexia Nervosa1
Anxiety Disorders1
Binge-Eating Disorder1
Bulimia Nervosa1
Consciousness Disorders1
Depressive Disorder1
Diabetes Complications1
Diabetes Mellitus1
Diabetes Mellitus, Type 21

Trials

Showing 1 to 5 of 5. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.